KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Inventory Average: 2010-2025

Historic Inventory Average for Emergent BioSolutions (EBS) over the last 15 years, with Sep 2025 value amounting to $347.4 million.

  • Emergent BioSolutions' Inventory Average rose 8.54% to $347.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $347.4 million, marking a year-over-year increase of 8.54%. This contributed to the annual value of $320.3 million for FY2024, which is 5.74% down from last year.
  • Emergent BioSolutions' Inventory Average amounted to $347.4 million in Q3 2025, which was up 6.48% from $326.3 million recorded in Q2 2025.
  • Emergent BioSolutions' Inventory Average's 5-year high stood at $476.9 million during Q3 2022, with a 5-year trough of $312.9 million in Q1 2025.
  • Over the past 3 years, Emergent BioSolutions' median Inventory Average value was $331.1 million (recorded in 2024), while the average stood at $336.1 million.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 63.72% in 2021, then decreased by 25.72% in 2023.
  • Emergent BioSolutions' Inventory Average (Quarterly) stood at $354.6 million in 2021, then rose by 23.95% to $439.4 million in 2022, then dropped by 22.29% to $341.5 million in 2023, then fell by 7.12% to $317.2 million in 2024, then rose by 8.54% to $347.4 million in 2025.
  • Its Inventory Average was $347.4 million in Q3 2025, compared to $326.3 million in Q2 2025 and $312.9 million in Q1 2025.